Ubrelvy 100 MG tablet UD 10S

Ended Awarded Last action

Contract number
SPE2DR26F8ALP
Awardee
Awarding agency
Obligated
$13,591

Award facts

Contract value 100% obligated
$13,591.46 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 12, 2026, with a ceiling value of $13,591.46 for UBRELVY 100 MG tablets, under a parent Indefinite Delivery Contract with the DLA Troop Support Medical.

The parent IDC, valued at up to $999,999,999.00 and running through December 2026, is a global pharmaceutical supply vehicle supporting military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and an ultimate completion date of April 13, 2026. No set-aside was used.

Quick answers

Who was awarded contract SPE2DR26F8ALP?

SPE2DR26F8ALP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 12, 2026.

How much is contract SPE2DR26F8ALP worth?

The government has obligated $13,591 on SPE2DR26F8ALP.

Is contract SPE2DR26F8ALP an order under another contract?

Yes. SPE2DR26F8ALP is a delivery order under SPE2DR25D7066, an indefinite delivery contract.

Was contract SPE2DR26F8ALP competed?

The extent of competition for SPE2DR26F8ALP was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award